Leerink Swann Initiates Trillium Therapeutics At Outperform
April 27, 2015 at 09:18 AM EDT
Analysts at Leerink Swann initiated coverage on Trillium Therapeutics Inc (NASDAQ: TRIL) with a Outperform rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.